Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
C4992 2'-Deoxyadenosine-5'-monophosphateSummary: A nucleic acid derivative used for research on DNA synthesis and damage repair. -
C4998 10-NitrooleateSummary: A nitrated fatty acid derivative with antioxidant and anti-inflammatory properties. -
C5088 Tilorone (hydrochloride)Summary: An interferon inducer with broad-spectrum antiviral activity. -
C5152 1-Methylnicotinamide (chloride)Summary: An endogenous metabolite with antithrombotic and anti-inflammatory effects. -
C5153 LEI-106Summary: A research tool for lipid signaling pathway studies with dual inhibition of DAGL-α and ABHD6. -
C5157 HexadecanalSummary: A long-chain fatty aldehyde that can be used for research on startle responses, aggressive behavior, and social behavior. -
C5158 L-(+)-ErgothioneineSummary: An antioxidant that can selectively inhibit the p38-MAPK and Akt pathways. -
C5175 4-Aminobenzoic acid hydrazideSummary: An irreversible covalent MPO inhibitor for stroke research. -
C5184 tetranor-PGEMSummary: A prostaglandin E2 metabolite for evaluating inflammation- and cancer-related biomarkers. -
C5211 IsovaleroylglycineSummary: A biomarker that can reflect lipid metabolism disorders and obesity.
